The buying spree precedes the seasonally strong quarters of March and June at a time when the stock has lost over 14% from the peak of ₹1,971.2 seen in early November 2022 making it among the cheapest stocks in the fast-moving consumer goods (FMCG) sector.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This